iBio (IBIO) Consolidated Net Income (2009 - 2026)
iBio's Consolidated Net Income came in at -$10.6 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$5.16 million a year earlier.
Powered by 
Analysis
iBio (IBIO) Consolidated Net Income (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio's Consolidated Net Income was -$33.04 million.
- Going back by fiscal year, Consolidated Net Income was -$18.38 million in FY2025, -$24.91 million in FY2024, -$65.01 million in FY2023 and -$50.3 million in FY2022.
- The fiscal Q4 2026 figure represents the lowest quarterly Consolidated Net Income since fiscal Q2 2023.
- Business Quant data shows IBIO's Consolidated Net Income at -$7.73 million (Q3 2026), -$8.99 million (Q2 2026) and -$5.72 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | -7.63 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -7.63 Bn |
| Jun 30, 2026 | -10.63 Mn |
| Mar 31, 2026 | -7.76 Mn |
| Dec 31, 2025 | -8.97 Mn |
| Sep 30, 2025 | -5.74 Bn |
| Jun 30, 2025 | -5.16 Mn |
| Mar 31, 2025 | -4.86 Mn |
| Dec 31, 2024 | -4.36 Mn |
| Sep 30, 2024 | -3.99 Bn |
| Jun 30, 2024 | -24.89 Bn |
| Mar 31, 2024 | -3.17 Mn |
| Dec 31, 2023 | -8.21 Mn |
| Sep 30, 2023 | -5.75 Mn |
| Jun 30, 2023 | -64.95 Bn |
| Mar 31, 2023 | -7.29 Mn |
| Dec 31, 2022 | -33.55 Mn |
| Sep 30, 2022 | -18.13 Mn |
| Jun 30, 2022 | -17.05 Mn |
| Mar 31, 2022 | -12.39 Mn |
| Dec 31, 2021 | -11.92 Mn |
API Access
iBio Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();